Global End-to-End Biologics CDMO

Global end-to-end CDMO specializing in protein-based biologics. With over 20 years of experience in EU and 205+ successful client programs, we provide integrated solutions — from cell line development to manufacturing of cGMP Drug Substance and Drug Product.
Our cGMP facilities in Lithuania, and Massachusetts (MA), support rapid, scalable manufacturing from early development to commercial phases. Known for scientific excellence, regulatory compliance, and a collaborative approach, Northway Biotech helps clients accelerate drug development with speed, precision, and flexibility.